Verra Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
127 Asbury Rd, Ithaca, New York, 14882, ...Phone Number
(607) 227-6828Website
www.verratherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Verra Therapeutics
Verra Therapeutics is a privately held company focused on transforming the treatment of protease-driven diseases through an innovative small protein platform. Founded in 2017, the company is developing preclinical drug candidates for conditions such as COPD and post-heart attack recovery, utilizing nature's evolved inhibitor sequences for targeted therapy. Their lead products, VTH144 and VTH245, aim to provide selective and impactful treatments while minimizing side effects associated with traditional therapies. Verra's mission is to address significant unmet medical needs in inflammatory and fibrotic diseases, ultimately improving patient outcomes.Explore more
Popular SearchesVerra Therapeutics LLCVerra TherapeuticsVerratherapeuticsSIC Code 87,873NAICS Code 54,541Show more
Verra Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Verra Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Verra Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Verra Therapeutics is spiking on competitors!
Product Launch: Get notified when Verra Therapeutics launches new products
Earning: See what the market has to say on Verra Therapeutics recently announced quarterly report
Verra Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Verra Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Verra Therapeutics
Funding: Get notified immidiatlly once Verra Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Verra Therapeutics
Compare insights from companies similar to Verra Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Verra Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Verra Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Verra Therapeutics.
Verra Therapeutics financials insights
Gather financial insights about Verra Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$205K
Verra Therapeutics Tech Stack
A closer look at the technologies used by Verra Therapeutics
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Verra Therapeutics
Sign Up For FreeTo access detailed company insights
Verra Therapeutics is a privately held company focused on transforming the treatment of protease-driven diseases through an innovative small protein platform. Founded in 2017, the company is developing preclinical drug candidates for conditions such as COPD and post-heart attack recovery, utilizing nature's evolved inhibitor sequences for targeted... Read More
